EUVIMED · CrossrefZeitschrift
Neoplasia
ISSN 1476-5586 · Elsevier BV
Neueste Artikel
TMPRSS4 promotes cancer stem-like properties in colon and lung cancers through transcriptional and post-transcriptional upregulation of KRAS
Spatial multi-omics and AI for decoding tumor heterogeneity: implications for target discovery and therapy resistance
Targeting the ac4C writer NAT10: unravelling metabolic dependencies and therapeutic opportunities in cancer
ISR addiction: Co-opting a stress sentinel to fuel tumor resilience and therapy resistance
S100A11 promotes immunosuppressive tumour-associated macrophage polarisation with SIRT6-associated changes in SMAD3 acetylation and SMAD2/3 activation in colorectal cancer
αvβ3 integrin recycling is associated with the intracellular trafficking and efflux of cRGDfK-modified PLGA nanoparticles
Preserving malignant provenance in single-cell cancer atlases: lessons from Ewing sarcoma plasticity
Treatment-associated remodeling of a mitochondrial translation-related gene set in paired pretreatment and residual triple-negative breast tumors
Epitranscriptomic regulation contributes to multiple myeloma biology and offers potential therapeutic targets
Corrigendum to “RUNX2 enhances bladder cancer progression by promoting glutamine metabolism” [Neoplasia 60 (2025) 101120, doi: 10.1016/j.neo.2024.101120]
RSPO1–LGR4 axis drives cervical cancer progression via activation of the EGFR/Src/ERK/AKT signaling pathway
Engineering CAR-T cell therapies for digestive tract cancer: advances, challenges, and strategies to overcome tumor heterogeneity and immunosuppressive barriers
Comprehensive multi-omics analysis identifies BTG2 as a potential regulator of radiotherapy response in lung adenocarcinoma
Ubiquitin-specific proteases and the immune microenvironment in cervical cancer: mechanistic evidence, immunotherapy resistance, and therapeutic perspectives
An intron retention-derived secreted Endoglin Isoform as a circulating biomarker in pancreatic ductal adenocarcinoma
Tumor-specific super-enhancer drives overexpression of EVI1/MECOM in ovarian cancer
Recent advances in cancer-associated fibroblasts in colorectal cancer: functional subtypes, spatiotemporal dynamics and therapeutic targets
Antigen persistence after antibody-drug conjugates in urothelial carcinoma: implications for CAR-cell target selection
Molecular subgroups of human malignant peripheral nerve sheath tumors are conserved in canines
Co-mutation of KRAS and ARID1A correlates with the MSI/LINE-1 hypermethylation profile in endometrial carcinoma
Survival outcomes, prognostic factors, and molecular landscape of early-onset versus late-onset colorectal cancer: a SEER-based study with external validation and transcriptomic profiling
LncRNA Signatures Associated with Exhausted CD8⁺T cells for Assessing the Immune Microenvironment and Drug Sensitivity in Pancreatic Adenocarcinoma
The Landscape of Nanotechnology in Esophageal Squamous Cell Carcinoma Treatment
Enhancing TCR-T cell responses with a TGFβ-specific chimeric antigen receptor
Decoding tumor immune microenvironment heterogeneity by single-cell and spatial multi-omics: From immunotherapy resistance to translational biomarkers
Heterogeneous SPP1-expressing esophageal cancer cells license immunotherapy resistance by organizing an immunosuppressive niche
Low dose radiotherapy-induced tumor-preferential antigens enhance antibody-drug conjugate efficacy in solid tumors
The partner gene modulates response to asciminib in ABL1-rearranged Acute Lymphoblastic Leukemia
A malignant symbiosis: The neuro-metabolic symphony rewires the tumor microenvironment
A MYC family switch: L-MYC drives and maintains neuroendocrine lineage programs in prostate cancer
EUVIMED